FreeTheAI

Halozyme Therapeutics, Inc.

HALO · NASDAQ · USD

$111.30

+1.45 1.32%todayNot financial advice.

HALO Price chart 6M
Open
109.70
Day range
109.70 - 111.65
52-week range
61.23 - 116.85
Volume
76.52K
Market cap
12.63B
P/E ratio
33.25
EPS
3.52
Dividend yield
0.00%
Beta
0.67

Performance

W

+4.05%

1M

+3.37%

3M

+41.20%

6M

+65.27%

YTD

+64.37%

Y

+70.70%

5Y

+188.40%

All

+2,867.87%

In the news

  1. Oct 8

    Halozyme Wins European Court Order Blocking Merck's Keytruda SC

    A Dutch court blocked Merck from selling its subcutaneous Keytruda in eight European nations, giving Halozyme a key patent victory.

    Company news

  2. Oct 7

    Halozyme Secures European Injunction Blocking Merck's Keytruda SC

    Halozyme Therapeutics secured a European court injunction blocking Merck's Keytruda SC, strengthening its IP position and disrupting a rival product.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-HALO" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Halozyme Therapeutics, Inc. (HALO) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-HALO">HALO stock price</a> by FreeTheAI Stocks</p>